TY  - JOUR 
AU  - Bermejo Martín, Jesús Francisco
AU  - Ortiz de Lejarazu, Raul
AU  - Pumarola, Tomas
AU  - Rello, Jordi
AU  - Almansa, Raquel
AU  - Ramírez, Paula
AU  - Martin-Loeches, Ignacio
AU  - Varillas, David
AU  - Gallegos, Maria C
AU  - Serón, Carlos
AU  - Micheloud, Dariela
AU  - Gomez, Jose Manuel
AU  - Tenorio-Abreu, Alberto
AU  - Ramos, María J
AU  - Molina, M Lourdes
AU  - Huidobro, Samantha
AU  - Sanchez, Elia
AU  - Gordón, Mónica
AU  - Fernández, Victoria
AU  - Del Castillo, Alberto
AU  - Marcos, Ma Angeles
AU  - Villanueva, Beatriz
AU  - López, Carlos Javier
AU  - Rodríguez-Domínguez, Mario
AU  - Galan, Juan-Carlos
AU  - Cantón, Rafael
AU  - Lietor, Aurora
AU  - Rojo, Silvia
AU  - Eiros, Jose M
AU  - Hinojosa, Carmen
AU  - Gonzalez, Isabel
AU  - Torner, Nuria
AU  - Banner, David
AU  - Leon, Alberto
AU  - Cuesta, Pablo
AU  - Rowe, Thomas
AU  - Kelvin, David J
PY  - 2009
UR  - http://hdl.handle.net/10366/161076
AB  - [EN] Human host immune response following infection with the new variant of A/H1N1 pandemic influenza virus (nvH1N1) is poorly understood. We utilize here systemic cytokine and antibody levels in evaluating differences in early immune response in both...
LA  - eng
KW  - Chemokines
KW  - Cytokines
KW  - DNA Primers
KW  - Hemagglutination Inhibition Tests
KW  - Influenza A Virus, H1N1 Subtype
KW  - Intensive Care Units
KW  - Severity of Illness Index
KW  - Viral Load
KW  - Adult
KW  - Length of Stay
KW  - Humans
KW  - Middle Aged
KW  - Hemagglutination Inhibition Tests
KW  - Intensive Care Units
KW  - RNA
KW  - Severity of Illness Index
KW  - Influenza A virus
KW  - Chemokines
KW  - Cytokines
KW  - DNA Primers
KW  - Patient Selection
KW  - Th1 Cells
TI  - Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.
DO  - 10.1186/cc8208
T2  - Critical care (London, England)
VL  - 13
M2  - R201
ER  -